L. A. Aarden and E. R. De-groot, Immunology of DNA. III. Crithidialuciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique, pp.505-520, 1975.

M. Akaiwa and Y. Yae, Hakata Antigen, a New Member of the Ficolin/Opsonin p35 Family, Is a Novel Human Lectin Secreted into Bronchus/Alveolus and Bile, Journal of Histochemistry & Cytochemistry, vol.89, issue.6, pp.777-86, 1999.
DOI : 10.1172/JCI115861

E. Akhter and R. W. Burlingame, Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers, Lupus, vol.35, issue.12, pp.1267-74, 2011.
DOI : 10.1056/NEJMoa051135

H. Almoallim and Y. Ghamdi, Anti-Tumor Necrosis Factor-?? Induced Systemic Lupus Erythematosus, The Open Rheumatology Journal, vol.6, issue.1, pp.315-324, 2012.
DOI : 10.2174/1874312901206010315

T. Andersen and L. Munthe-fog, Serum Levels of Ficolin-3 (Hakata Antigen) in Patients with Systemic Lupus Erythematosus, The Journal of Rheumatology, vol.36, issue.4, pp.757-766, 2009.
DOI : 10.3899/jrheum.080361

A. Antico and S. Platzgummer, Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test, Lupus, vol.3, issue.8, pp.19-906, 2010.
DOI : 10.1177/0961203310362995

G. Bertsias and J. P. Ioannidis, EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics, Annals of the Rheumatic Diseases, vol.67, issue.2, pp.195-205, 2008.
DOI : 10.1136/ard.2007.070367

N. Bizzaro and D. Villalta, Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis, Autoimmunity Reviews, vol.12, issue.2, pp.97-106, 2012.
DOI : 10.1016/j.autrev.2012.07.002

A. B. Boldt and I. Goeldner, Relevance of the lectin pathway of complement in rheumatic diseases, Adv Clin, vol.56, pp.105-53, 2012.
DOI : 10.1016/B978-0-12-394317-0.00012-1

C. Bombardier and D. D. Gladman, Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE, Arthritis Rheum35, issue.6, pp.630-670, 1992.

A. T. Borchers and S. M. Naguwa, The geoepidemiology of systemic lupus erythematosus, Autoimmunity Reviews, vol.9, issue.5, pp.277-87, 2010.
DOI : 10.1016/j.autrev.2009.12.008

A. T. Borchers and N. Leibushor, Lupus nephritis: A critical review, Autoimmunity Reviews, vol.12, issue.2, pp.174-94, 2012.
DOI : 10.1016/j.autrev.2012.08.018

V. Garlatti and N. Belloy, Structural insights into the innate immune recognition specificities of L- and H-ficolins, The EMBO Journal, vol.172, issue.2, pp.623-656, 2007.
DOI : 10.1038/sj.emboj.7601500

J. Goetz, Conduite à tenir devant la mise en évidence d'anticorps antinucléaires sur HEp2, pp.7-11, 2012.

J. Goetz, Marqueurs biologiques anciens et modernes du lupus ??ryth??mateux syst??mique, Revue du Rhumatisme, vol.72, issue.2, pp.134-141, 2005.
DOI : 10.1016/j.rhum.2004.12.007

J. A. Gomez-puerta and R. W. Burlingame, Anti-chromatin (anti-nucleosome) antibodies: Diagnostic and clinical value, Autoimmunity Reviews, vol.7, issue.8, pp.606-617, 2008.
DOI : 10.1016/j.autrev.2008.06.005

M. R. Gonzalez-crespo and J. I. Lopez-fernandez, Outcome of silent lupus nephritis, Seminars in Arthritis and Rheumatism, vol.26, issue.1, pp.468-76, 1996.
DOI : 10.1016/S0049-0172(96)80027-8

B. H. Hahn, Antibodies to DNA, N Engl J Med338, pp.1359-68, 1998.

M. M. Hargraves and H. Richmond, Presentation of two bone marrow elements; the tart cell and the L.E. cell, Proc Staff Meet Mayo, vol.23, issue.2, pp.25-33, 1948.

M. Hernando and C. Gonzalez, Clinical Evaluation of a New Automated Anti-dsDNA Fluorescent Immunoassay, Clinical Chemistry and Laboratory Medicine, vol.40, issue.10, pp.1056-60, 2002.
DOI : 10.1515/CCLM.2002.185

A. Ho and L. S. Magder, Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus, Arthritis & Rheumatism, vol.132, issue.10, pp.2342-2351, 2001.
DOI : 10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8

M. C. Hochberg, Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.74, issue.9, p.1725, 1997.
DOI : 10.1002/art.1780400928

U. Holmskov and S. Thiel, : Humoral Lectins of the Innate Immune Defense, Annual Review of Immunology, vol.21, issue.1, pp.547-78, 2002.
DOI : 10.1146/annurev.immunol.21.120601.140954

C. Honore and T. Hummelshoj, The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells, Arthritis & Rheumatism, vol.156, issue.5, pp.1598-607, 2007.
DOI : 10.1002/art.22564

T. Hummelshoj and L. M. Fog, Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen), Molecular Immunology, vol.45, issue.6, pp.1623-1655, 2008.
DOI : 10.1016/j.molimm.2007.10.006

K. Iida and R. Mornaghi, Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus, Journal of Experimental Medicine, vol.155, issue.5, pp.1427-1465, 1982.
DOI : 10.1084/jem.155.5.1427

S. Inaba and K. Okochi, On a new precipitating antibody against normal human serum found in two patients with SLE in Japanese, J Clin Exp, vol.107, pp.690-691, 1978.

S. Inaba and K. Okochi, Serological studies of an SLE-associated antigen-antibody system discovered as a precipitation reaction in agarose gel: the HAKATA antigen-antibody system, Fukuoka Igaku, vol.81, issue.9, pp.284-91, 1990.

D. A. Isenberg and J. J. Manson, Fifty years of anti-ds DNA antibodies: are we approaching journey's end?, Rheumatology, vol.46, issue.7, pp.1052-1058, 2007.
DOI : 10.1093/rheumatology/kem112

C. Johanet and C. André, Signification clinique des anticorps antiribosomes, La Revue de M??decine Interne, vol.21, issue.6, pp.510-516, 2000.
DOI : 10.1016/S0248-8663(00)89226-7

N. Jourde-chiche and L. Daniel, Association between anti-C1q antibodies and glomerular tuft necrosis in lupus nephritis, Clinical Nephrology, vol.77, issue.03, pp.211-219, 2012.
DOI : 10.5414/CN107274

C. G. Kallenberg, Anti-C1q autoantibodies, Autoimmunity Reviews, vol.7, issue.8, pp.612-617, 2008.
DOI : 10.1016/j.autrev.2008.06.006

Y. Katsumata and K. Miyake, Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: A controlled study of 126 consecutive patients, Arthritis & Rheumatism, vol.199, issue.8, pp.63-2436, 2011.
DOI : 10.1002/art.30401

U. Katz and G. Zandman-goddard, Drug-induced lupus: An update, Autoimmunity Reviews, vol.10, issue.1, pp.46-50, 2010.
DOI : 10.1016/j.autrev.2010.07.005

A. F. Kavanaugh and D. H. Solomon, Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti-DNA antibody tests, Arthritis & Rheumatism, vol.44, issue.5, pp.546-55, 2002.
DOI : 10.1002/art.10558

D. Koffler and P. H. Schur, IMMUNOLOGICAL STUDIES CONCERNING THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS, Journal of Experimental Medicine, vol.126, issue.4, pp.607-631, 1967.
DOI : 10.1084/jem.126.4.607

A. Krarup and U. B. Sorensen, Effect of Capsulation of Opportunistic Pathogenic Bacteria on Binding of the Pattern Recognition Molecules Mannan-Binding Lectin, L-Ficolin, and H-Ficolin, Infection and Immunity, vol.73, issue.2, pp.73-1052, 2005.
DOI : 10.1128/IAI.73.2.1052-1060.2005

M. Kuraya and Z. Ming, Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation, Immunobiology, vol.209, issue.9, pp.689-97, 2005.
DOI : 10.1016/j.imbio.2004.11.001

D. Launay and J. Schmidt, Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus, Clinica Chimica Acta, vol.411, issue.13-14, pp.13-14, 2010.
DOI : 10.1016/j.cca.2010.03.016

R. Lemarié and F. Jacomet, Les anticorps anti-ADN natif : validation d'une stratégie de détection en deux temps, Ann Biol Clin, vol.69, issue.1, pp.47-53, 2011.

B. L. Liphaus and M. H. Kiss, The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus, Clinics, vol.65, issue.3, pp.327-360, 2010.
DOI : 10.1590/S1807-59322010000300014

J. Lu and C. Teh, Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1572, issue.2-3, pp.387-400, 2002.
DOI : 10.1016/S0304-4165(02)00320-3

M. Macanovic and M. B. Hogarth, Anti-DNA antibodies in the urine of lupus nephritis patients, Nephrology Dialysis Transplantation, vol.14, issue.6, pp.1418-1442, 1999.
DOI : 10.1093/ndt/14.6.1418

P. J. Maddison, ANA-negative SLE, Clin Rheum, vol.8, issue.1, pp.105-124, 1982.

M. Mahler and K. Miyachi, The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA), Autoimmunity Reviews, vol.11, issue.10, pp.771-776, 2012.
DOI : 10.1016/j.autrev.2012.02.012

J. Martin and C. Durant, Evaluation of two antibodies against double-stranded DNA assays in discriminating between active and non-active systemic lupus erythematosus: Correlation between the cut-off and the specificity, Pathologie Biologie, vol.60, issue.6, pp.387-91, 2011.
DOI : 10.1016/j.patbio.2011.12.003

A. Matrat and C. Veysseyre-balter, Simultaneous detection of anti-C1q and antidouble stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares, pp.20-28, 2011.

M. Matsushita and Y. Endo, A novel human serum lectin with collagen-and fibrinogenlike domains that functions as an opsonin, J Biol, vol.271, issue.5, pp.2448-54, 1996.

M. Matsushita and M. Kuraya, Activation of the lectin complement pathway by Hficolin (Hakata antigen), J Immunol168, issue.7, pp.3502-3508, 2002.

M. Matsushita and Y. Endo, Structural and Functional Overview of the Lectin Complement Pathway: Its Molecular Basis and Physiological Implication, Archivum Immunologiae et Therapiae Experimentalis, vol.172, issue.4, pp.273-83, 2013.
DOI : 10.1007/s00005-013-0229-y

L. J. Mccloskey and P. Christner, Myth and reality: practical test system for the measurement of anti-DNA antibodies in the diagnosis of systemic lupus erythematosus (SLE), Journal of Clinical Laboratory Analysis, vol.15, issue.2, pp.77-84, 2010.
DOI : 10.1002/jcla.20358

O. C. Meyer and P. Nicaise-roland, Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus, Arthritis Research & Therapy, vol.11, issue.3, p.87, 2009.
DOI : 10.1186/ar2725

O. C. Meyer and M. F. Khan, Lupus érythémateux systémique, Maladies et syndromes systémiques, pp.131-368, 2000.

M. Michalski and A. Szala, H-ficolin (ficolin-3) concentrations and FCN3 gene polymorphism in neonates, Immunobiology, vol.217, issue.7, pp.730-737, 2012.
DOI : 10.1016/j.imbio.2011.12.004

P. Migliorini and C. Baldini, Anti-Sm and anti-RNP antibodies, Autoimmunity, vol.7, issue.2, pp.47-54, 2005.
DOI : 10.1080/08916930400022715

K. Miyachi and M. J. Fritzler, Autoantibody to a nuclear antigen in proliferating cells, J Immunol121, issue.6, pp.2228-2262, 1978.

O. A. Monticielo and T. Mucenic, The role of mannose-binding lectin in systemic lupus erythematosus, Clinical Rheumatology, vol.1108, issue.7, pp.413-422, 2008.
DOI : 10.1007/s10067-008-0838-8

C. A. Ogden, C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells, The Journal of Experimental Medicine, vol.142, issue.6, pp.781-95, 2001.
DOI : 10.1038/77835

M. Okamura and Y. Kanayama, Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology., Annals of the Rheumatic Diseases, vol.52, issue.1, pp.14-20, 1993.
DOI : 10.1136/ard.52.1.14

K. Op-de-beeck and P. Vermeersch, Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay, Autoimmunity Reviews, vol.10, issue.12, pp.801-809, 2011.
DOI : 10.1016/j.autrev.2011.06.005

N. Palaniyar and J. Nadesalingam, Nucleic Acid Is a Novel Ligand for Innate, Immune Pattern Recognition Collectins Surfactant Proteins A and D and Mannose-binding Lectin, Journal of Biological Chemistry, vol.279, issue.31, pp.32728-32764, 2004.
DOI : 10.1074/jbc.M403763200

V. Pascual and L. Farkas, Systemic lupus erythematosus: all roads lead to type I interferons, Current Opinion in Immunology, vol.18, issue.6, pp.676-82, 2006.
DOI : 10.1016/j.coi.2006.09.014

L. Paul and V. M. Skanes, C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1, Complement5, issue.3, pp.110-119, 1988.

A. J. Pesce and N. Mendoza, Use of enzyme-linked antibodies to measure serum anti- DNA antibody in systemic lupus erythematosus, Clin, vol.20, issue.3, pp.353-362, 1974.

T. Pincus and P. H. Schurr, A diagnostic test for systemic lupus erythematosus using a DNA binding essay, Arth Rheum, pp.837-839, 1968.

E. Potlukova and P. Kralikova, Complement Component C1q and Anti-C1q Antibodies in Theory and in Clinical Practice, Scandinavian Journal of Immunology, vol.29, issue.5, pp.423-453, 2008.
DOI : 10.1111/j.1365-2249.2006.03153.x

M. Radanova and V. Vasilev, Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP, Immunobiology, vol.217, issue.7, pp.217-684, 2012.
DOI : 10.1016/j.imbio.2011.11.007

C. T. Ravirajan and L. Rowse, An analysis of clinical disease activity and nephritisassociated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study, Rheumatology (Oxford), issue.12, pp.40-1405, 2001.

J. Romero-diaz and D. Isenberg, Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI), pp.37-46, 2004.

N. Sato and I. Ohsawa, Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis, Lupus, vol.3, issue.13, pp.1378-86, 2011.
DOI : 10.1002/art.1780400928

M. A. Seelen and L. A. Trouw, Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus, Current Opinion in Nephrology and Hypertension, vol.12, issue.6, pp.619-643, 2003.
DOI : 10.1097/00041552-200311000-00008

M. Seligmann, [Demonstration in the blood of patients with disseminated lupus erythematosus a substance determining a precipitation reaction with desoxyribonucleic acid], C R Hebd Seances Acad, vol.245, issue.2, pp.243-248, 1957.

R. Seror, Critères de jugement et maladies systémiques, mesure de l'activité du lupus érythémateux systémique, DIU maladies systémiquesHôpital Bicêtre, 2012.

A. G. Sjoholm and G. Jonsson, Complement deficiency and disease: An update, Molecular Immunology, vol.43, issue.1-2, pp.78-85, 2006.
DOI : 10.1016/j.molimm.2005.06.025

Y. Su and R. L. Jia, Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus, Clinical Immunology, vol.122, issue.1, pp.115-135, 2007.
DOI : 10.1016/j.clim.2006.10.003

R. Sugimoto and Y. Yae, Cloning and Characterization of the Hakata Antigen, a Member of the Ficolin/Opsonin p35 Lectin Family, Journal of Biological Chemistry, vol.273, issue.33, pp.20721-20728, 1998.
DOI : 10.1074/jbc.273.33.20721

B. B. Suh-lailam and T. R. Chiaro, Evaluation of a high avidity anti-dsDNA IgG enzymelinked immunosorbent assay for the diagnosis of systemic lupus erythematosus, Int J Clin Exp, issue.8, pp.4-748, 2011.

M. Sui and Q. Lin, Simultaneous positivity for anti-DNA, anti-nucleosome and antihistone antibodies is a marker for more severe lupus nephritis, J Clin, vol.33, issue.2, pp.378-87, 2013.

A. Swierzko and J. Lukasiewicz, New functional ligands for ficolin-3 among lipopolysaccharides of Hafnia alvei, Glycobiology, vol.22, issue.2, pp.267-80, 2012.
DOI : 10.1093/glycob/cwr119

K. Takahashi and W. E. Ip, The mannose-binding lectin: a prototypic pattern recognition molecule, Current Opinion in Immunology, vol.18, issue.1, pp.16-23, 2006.
DOI : 10.1016/j.coi.2005.11.014

M. Takahashi and B. F. Tack, Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes, Journal of Experimental Medicine, vol.145, issue.1, pp.86-100, 1977.
DOI : 10.1084/jem.145.1.86

R. Takahashi and A. Tsutsumi, Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus, Clinical and Experimental Immunology, vol.79, issue.100, pp.585-90, 2004.
DOI : 10.1182/blood-2002-04-1033

R. Tozzoli and N. Bizzaro, Guidelines for the Laboratory Use of Autoantibody Tests in the Diagnosis and Monitoring of Autoimmune Rheumatic Diseases, American Journal of Clinical Pathology, vol.117, issue.2, pp.316-340, 2002.
DOI : 10.1309/Y5VF-C3DM-L8XV-U053

M. Trendelenburg, Antibodies against C1q in patients with systemic lupus erythematosus, Springer Seminars in Immunopathology, vol.42, issue.3, pp.276-85, 2005.
DOI : 10.1007/s00281-005-0007-y

L. Truedsson and A. A. Bengtsson, Complement deficiencies and systemic lupus erythematosus, Autoimmunity, vol.73, issue.6, pp.560-566, 2007.
DOI : 10.1161/01.CIR.0000019584.04929.83

S. Uwatoko and S. Aotsuka, Characterization of C1q-binding IgG complexes in systemic lupus erythematosus, Clinical Immunology and Immunopathology, vol.30, issue.1, pp.104-120, 1984.
DOI : 10.1016/0090-1229(84)90011-4

A. Verma and M. White, Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses, The Journal of Immunology, vol.189, issue.5, pp.2478-87, 2012.
DOI : 10.4049/jimmunol.1103786

D. Wakasugi and T. Gono, Frequency of Class III and IV Nephritis in Systemic Lupus Erythematosus Without Clinical Renal Involvement: An Analysis of Predictive Measures, The Journal of Rheumatology, vol.39, issue.1, pp.79-85, 2012.
DOI : 10.3899/jrheum.110532

H. Watanabe and R. Saito, Serum L-ficolin levels in patients with systemic lupus erythematosus, Modern Rheumatology, vol.36, issue.6, pp.899-902, 2012.
DOI : 10.3109/s10165-012-0616-y

J. J. Weening and V. D. Agati, The classification of glomerulonephritis in systemic lupus erythematosus revisited, Kidney International, vol.65, issue.2, pp.521-551, 2004.
DOI : 10.1111/j.1523-1755.2004.00443.x

L. Weiss, Biologie des déficits en complément, Méd thérapeutique, vol.6, issue.2, pp.155-161, 2000.

R. T. Wold and F. E. Young, Deoxyribonucleic Acid Antibody: A Method to Detect Its Primary Interaction with Deoxyribonucleic Acid, Science, vol.161, issue.3843, pp.806-813, 1968.
DOI : 10.1126/science.161.3843.806

M. Yamada and K. Oritani, Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells, European Journal of Immunology, vol.34, issue.1, pp.221-251, 2004.
DOI : 10.1002/eji.200324026

S. Yoshizawa and K. Nagasawa, A thermolabile ??2-macroglycoprotein (TMG) and the antibody against TMG in patients with systemic lupus erythematosus, Clinica Chimica Acta, vol.264, issue.2, pp.219-244, 1997.
DOI : 10.1016/S0009-8981(97)00078-8

R. M. Zacho and L. Jensen, Studies of the Pattern Recognition Molecule H-ficolin: SPECIFICITY AND PURIFICATION, Journal of Biological Chemistry, vol.287, issue.11, pp.8071-81, 2012.
DOI : 10.1074/jbc.M111.301044

X. L. Zhang and M. A. Ali, Ficolins: Structure, Function and Associated Diseases, Adv Exp Med, vol.632, pp.105-120, 2008.
DOI : 10.1007/978-0-387-78952-1_9